Search results
Mahesh Krishnan Elected to Halozyme's Board of Directors
WATE 6 Knoxville· 16 hours agoHalozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in ...
Erenumab Reduces Flushing and Erythema in Rosacea
Medscape· 2 days agoA calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea.
Recreational cannabis use may lower your risk of cognitive decline, study says
Fortune· 7 days agoResearchers at the State University of New York Upstate Medical University found that nonmedical cannabis use—regardless of how or how often it was consumed—lowered a person’s odds of subjective ...
